Data / Drug companies / Amerisource Bergen
Amerisource Bergen: 245 products in the FDA NDC directory, labeler code 46122
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Amerisource Bergen (labeler code 46122) lists 245 products in the FDA National Drug Code Directory, covering 129 finished drugs by generic name. By type: 245 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on November 5, 2026.
The request: Watch Amerisource Bergen (FDA labeler code 46122): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 46122
- Products in commercial distribution
- 245
- Packages
- 308
- Finished drugs by generic name
- 129
- Prescription products
- 0
- Over the counter products
- 245
- Flagged as original packager
- 219 of 219 products that carry the flag
- Started marketing in the last 12 months
- 20
- Products with a marketing end date set
- 11
- Earliest marketing start
- August 25, 1981
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 152 | 62% |
| Generic drugs (ANDA) | 78 | 31.8% |
| New drug applications (NDA) | 11 | 4.5% |
| Other unapproved drugs | 4 | 1.6% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 245 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Liquid | 29 | 11.8% |
| Solution | 19 | 7.8% |
| Tablet, film coated | 18 | 7.3% |
| Tablet | 18 | 7.3% |
| Capsule, liquid filled | 14 | 5.7% |
| Tablet, chewable | 12 | 4.9% |
| Tablet, coated | 10 | 4.1% |
| Tablet, delayed release | 9 | 3.7% |
| Gum, chewing | 9 | 3.7% |
| Suspension | 9 | 3.7% |
| Patch | 9 | 3.7% |
| Tablet, extended release | 8 | 3.3% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Good neighbor pharmacy 24 hour nasal allergy | 46122-806 | Spray, metered | Generic drugs (ANDA) | November 5, 2026 |
| Hydrocortisone Cream 0.5% With Aloe | 46122-830 | Cream | Over the counter monograph drugs | November 2, 2026 |
| Liquid Corn and Callus | 46122-838 | Liquid | Over the counter monograph drugs | July 23, 2026 |
| Antifungal Liquid | 46122-839 | Aerosol, spray | Over the counter monograph drugs | July 7, 2026 |
| Nicotine Transdermal System step 1 | 46122-833 | Patch, extended release | New drug applications (NDA) | July 1, 2026 |
| Nicotine Transdermal System step 2 | 46122-832 | Patch, extended release | New drug applications (NDA) | July 1, 2026 |
| Nicotine Transdermal System step 3 | 46122-831 | Patch, extended release | New drug applications (NDA) | July 1, 2026 |
| Good neighbor pharmacy menstrual pain relief | 46122-836 | Tablet, film coated, extended release | Generic drugs (ANDA) | June 2, 2026 |
| Cetirizine HCl | 46122-815 | Capsule | New drug applications (NDA) | May 30, 2026 |
| Good neighbor pharmacy daytime flu relief max strength | 46122-841 | Powder, for solution | Over the counter monograph drugs | May 4, 2026 |
| Good neighbor pharmacy mucus relief dm maximum strength | 46122-840 | Solution | Over the counter monograph drugs | May 4, 2026 |
| Allergy Relief | 46122-829 | Tablet | Over the counter monograph drugs | May 4, 2026 |
| Olopatadine hydrochloride | 46122-824 | Solution | Generic drugs (ANDA) | May 1, 2026 |
| Olopatadine hydrochloride | 46122-823 | Solution | Generic drugs (ANDA) | May 1, 2026 |
| Hydrocortisone with Aloe | 46122-822 | Cream | Over the counter monograph drugs | April 13, 2026 |
| Ivermectin | 46122-827 | Lotion | Generic drugs (ANDA) | April 3, 2026 |
| Good Neighbor Pharmacy Dual Action Complete | 46122-345 | Tablet, chewable | Generic drugs (ANDA) | March 10, 2026 |
| Allergy Relief | 46122-828 | Capsule, liquid filled | Over the counter monograph drugs | March 9, 2026 |
| Pinworm treatment | 46122-825 | Suspension | Over the counter monograph drugs | January 21, 2026 |
| Stool Softener | 46122-826 | Capsule, liquid filled | Over the counter monograph drugs | January 1, 2026 |
| Good neighbor pharmacy mucus dm | 46122-817 | Tablet, extended release | Generic drugs (ANDA) | September 12, 2025 |
| Esomeprazole Magnesium | 46122-821 | Capsule, delayed release | Generic drugs (ANDA) | August 30, 2025 |
| Good Neighbor Pain Relief Patch With Lidocaine 4% | 46122-820 | Patch | Over the counter monograph drugs | August 1, 2025 |
| Good Neighbor Roll-on Menthol Pain Relief Gel | 46122-803 | Gel | Over the counter monograph drugs | August 1, 2025 |
| Good Neighbor Roll-on Pain Relief | 46122-802 | Liquid | Over the counter monograph drugs | August 1, 2025 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.